Security Snapshot

Edesa Biotech, Inc. - Common Stock (EDSA) Institutional Ownership

CUSIP: 27966L306

13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

27

Shares (Excl. Options)

2,643,718

Price

$5.23

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Stock
Symbol
EDSA on Nasdaq
All holders as of 31 Mar 2026
Q1 2026
Total 13F shares
2,643,718
Latest holder snapshot 5 signals
Total 13F value
$13,826,626
Portfolio coverage rank
0%
Share change
-495,840
Value change
+$763,438
Number of holders
27
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
8,882,429
SEC-reported price per share
$15.24
Insider filing price
$15.24
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • EDSA - Edesa Biotech, Inc. - Common Stock is tracked under CUSIP 27966L306.
  • 27 institutions reported positions in Q1 2026.
  • 7 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 21 to 27 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $4,339,133 to $13,826,626.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 27 institutions filings for Q1 2026.

Open SEC evidence

Security key

27966L306

Latest holder period

Q1 2026

13F holders

27

13D/G owners

7

CIK / CUSIP context first

Open Q1 2026 holders EDSA full holder history Edesa Biotech, Inc. SEC filings Edesa Biotech, Inc. company facts Edesa Biotech, Inc. insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
7
Security
EDSA
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nijhawan Pardeep 20% 0% $2,510,166 +$546,371 2,040,785 +28% Pardeep Nijhawan 26 Feb 2026
Velan Capital Investment Management LP 10% 0% $1,026,681 +$173,613 834,700 +20% Velan Capital Investment Management LP 26 Feb 2026
Rubric Capital Management LP 7.7% $4,056,250 687,500 Rubric Capital Management LP 31 Mar 2025
Sirenia Capital Management LP 7.2% $3,540,000 600,000 Sirenia Capital Management LP 31 Mar 2026
PERCEPTIVE ADVISORS LLC 6.7% $551,974 563,239 Perceptive Advisors LLC 09 Mar 2026
Stonepine Capital Management, LLC 0.3% -96% $177,000 -$3,914,951 30,000 -96% Stonepine Capital Management, LLC 31 Mar 2026
Point72 Asset Management, L.P. 0% -103% $11.8 -$3,539,988 2 -100% Point72 Asset Management, L.P. 31 Mar 2026

As of 31 Mar 2026, 27 institutional investors reported holding 2,643,718 shares of Edesa Biotech, Inc. - Common Stock (EDSA). This represents 30% of the company’s total 8,882,429 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
30%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Velan Capital Investment Management LP 9.3% 827,500 +20% 2.7% $4,327,825
Rubric Capital Management LP 7.7% 687,500 0% 0.04% $3,595,625
PERCEPTIVE ADVISORS LLC 6.3% 563,239 0.06% $2,945,740
JANE STREET GROUP, LLC 1.3% 115,721 0% $605,221
VANGUARD CAPITAL MANAGEMENT LLC 0.97% 85,966 0% 0% $449,602
GEODE CAPITAL MANAGEMENT, LLC 0.87% 77,054 +66% 0% $403,016
VANGUARD FIDUCIARY TRUST CO 0.43% 38,446 0% 0% $201,073
STATE STREET CORP 0.43% 37,979 +103% 0% $198,630
COMMONWEALTH EQUITY SERVICES, LLC 0.39% 35,003 0% $183,070
Scientech Research LLC 0.34% 30,534 0.13% $159,693
Stonepine Capital Management, LLC 0.34% 30,000 -96% 0.14% $156,900
BlackRock, Inc. 0.31% 27,709 0% $144,918
Virtu Financial LLC 0.3% 26,275 0.01% $137,000
Schonfeld Strategic Advisors LLC 0.22% 19,650 0% $102,768
SCOTIA CAPITAL INC. 0.18% 15,843 0% $82,859
NORTHERN TRUST CORP 0.17% 14,994 0% $78,419
SBI Securities Co., Ltd. 0.04% 3,502 0% $18,315
UBS Group AG 0.03% 2,343 +72% 0% $12,254
ROYAL BANK OF CANADA 0.02% 1,659 0% 0% $9,000
MCGUIRE CAPITAL ADVISORS INC 0.02% 1,500 0.01% $7,845
Tower Research Capital LLC (TRC) 0.01% 507 -80% 0% $2,652
CITIGROUP INC 0.01% 487 0% $2,547
Vanguard Global Advisers, LLC 0% 162 0% 0% $847
TD Waterhouse Canada Inc. 0% 142 0% 0% $792
LRI Investments, LLC 0% 1 0% 0% $5

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 2,643,718 $13,826,626 +$763,438 $5.23 27
2025 Q4 3,052,670 $4,339,133 +$168,466 $1.42 21
2025 Q3 2,876,709 $7,101,619 +$1,897,089 $2.47 23
2025 Q2 2,108,117 $4,279,068 -$1,739,763 $2.03 20
2025 Q1 2,822,207 $6,885,740 +$6,475,156 $2.44 19
2024 Q4 207,513 $350,110 +$46,292 $1.68 16
2024 Q3 161,348 $718,217 +$49,169 $4.45 17
2024 Q2 150,715 $645,126 +$183,339 $4.28 17
2024 Q1 107,880 $450,876 -$12,949 $4.19 17
2023 Q4 110,845 $507,117 +$507,117 $4.57 19
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .